XPON

Expion360 sells LiFePO4 batteries into RV, marine and industrial markets, and the top line is genuinely accelerating — FY2025 revenue of $9.65M was up 71.6% and reversed three flat-to-down years. But the quality of that growth is the problem: gross margin is just 13.9%, so the $1.34M of gross profit cannot begin to cover a cost base that produced a -$10.7M operating loss (operating margin -110.9%) and a -$6.24M net loss. This isn't a company one or two quarters from profitability; the accumulated deficit is -$40.8M against just $6.54M of equity, and ROE is -95.4%. The unit economics, not the demand, are what's broken.

The balance sheet looks superficially clean — liabilities/equity of only 0.23x, negligible debt ($166K long-term, $31K current) — but that solvency is manufactured by relentless equity issuance, and that is the whole story. Shares outstanding rose 244.9% YoY, and this is AFTER a 1-for-100 reverse split in October 2024. The filing spells out the treadmill: an October 2025 private placement at $1.65/share (net ~$1.1M, much of it consumed immediately by executive severance) and a December 2025 ATM under which they sold another 1.06M shares for ~$933K through March 2026. With $2.97M of cash against $6.15M of annual operating cash burn, the company has well under a year of runway and is visibly plugging it by selling stock into a falling price.